SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-22-032116
Filing Date
2022-11-14
Accepted
2022-11-14 16:34:05
Documents
68
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 1591276
2 ex31-1.htm EX-31.1 16975
3 ex32-1.htm EX-32.1 7664
  Complete submission text file 0001493152-22-032116.txt   8541653

Data Files

Seq Description Document Type Size
4 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ppcb-20220930.xsd EX-101.SCH 66334
5 INLINE XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT ppcb-20220930_cal.xml EX-101.CAL 65390
6 INLINE XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ppcb-20220930_def.xml EX-101.DEF 299731
7 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ppcb-20220930_lab.xml EX-101.LAB 533207
8 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ppcb-20220930_pre.xml EX-101.PRE 409834
62 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 1252613
Mailing Address 302/6 BUTLER STREET CAMBERWELL, VICTORIA C3 3124
Business Address 302/6 BUTLER STREET CAMBERWELL, VICTORIA C3 3124 61-03-9882-0780
Propanc Biopharma, Inc. (Filer) CIK: 0001517681 (see all company filings)

IRS No.: 300662986 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 000-54878 | Film No.: 221386522
SIC: 2834 Pharmaceutical Preparations